Free Trial

Immunome (IMNM) SEC Filings & 10K Form

Immunome logo
$9.90 -1.24 (-11.13%)
(As of 11/15/2024 ET)

Recent Immunome SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Immunome (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
9:33 AM
Immunome (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/13/2024
3:06 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:57 PM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:54 AM
Immunome (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/29/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Immunome (Subject)
Form SC 13G
10/08/2024
3:31 PM
Immunome (Filer)
Form S-3ASR
10/07/2024
6:14 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2024
6:26 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
1:18 PM
Immunome (Subject)
Rosett Max (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
8:05 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
8:07 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
2:21 PM
Higgins Jack (Reporting)
Immunome (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:48 PM
Immunome (Issuer)
Turner Bruce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:51 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:54 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:56 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:36 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:40 PM
Immunome (Issuer)
Lechleider Robert (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
4:43 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:10 PM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/18/2024
7:52 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:54 PM
Immunome (Issuer)
WAGENHEIM PHILIP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:56 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:59 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:01 PM
Boylan James P (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
8:05 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/18/2024
8:08 PM
Immunome (Issuer)
Tsai Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:48 PM
Barchas Isaac (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:05 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2024
3:49 PM
BIENAIME JEAN JACQUES (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:13 PM
Immunome (Issuer)
SIEGALL CLAY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
4:11 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
7:48 AM
Immunome (Filer)
Form 424B5
05/14/2024
7:05 AM
Immunome (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
7:02 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
7:14 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/29/2024
7:12 PM
Immunome (Issuer)
SWAIN SANDRA M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/26/2024
3:12 PM
Immunome (Filer)
Form ARS
04/25/2024
3:01 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
04/03/2024
3:40 PM
Immunome (Filer)
Form S-3ASR
03/28/2024
3:04 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:06 PM
Immunome (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
8:07 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2024
8:10 PM
Horn Kinney (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
1:10 PM
Alpine Global Management, LLC (Filed by)
Immunome (Subject)
Form SC 13G/A
02/06/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
8:18 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
7:50 PM
Immunome (Issuer)
Stoneman Sandra G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
7:53 PM
Immunome (Issuer)
Rosett Max (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
4:27 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
6:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:33 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:37 PM
Immunome (Issuer)
SCHAFER CAROL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:40 PM
Immunome (Issuer)
Lapetina Bob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2024
7:05 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:00 PM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
7:35 AM
Immunome (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
6:24 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/15/2023
6:28 PM
Immunome (Issuer)
Roberts Phil Noland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
8:08 PM
Higgins Jack (Reporting)
Immunome (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
11:15 PM
Immunome (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:IMNM) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners